Randomized Trial of Radiotherapy Versus Transoral Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma: Long-Term Results of the ORATOR Trial.
Anthony Charles NicholsJulie A TheurerEitan PrismanNancy ReadEric BertheletEric TranKevin FungJohn R De AlmeidaAndrew BayleyDavid P GoldsteinMichael HierKhalil SultanemKeith RichardsonAlex MlynarekSuren KrishnanHien LeJohn YooS Danielle MacNeilEric WinquistJ Alex HammondVaragur VenkatesanSara KuruvillaAndrew WarnerSylvia MitchellJeff ChenMartin CorstenStephanie Johnson-ObasekiMichael OdellChristina ParkerBret WehrliKeith KwanDavid A PalmaPublished in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
On longitudinal analysis, the swallowing QOL difference between primary RT and TORS + ND approaches persists but decreases over time. Patients with OPSCC should be informed about the pros and cons of both treatment options (ClinicalTrials.gov identifier: NCT01590355).